Viewing Study NCT03571360


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-03-02 @ 4:37 PM
Study NCT ID: NCT03571360
Status: UNKNOWN
Last Update Posted: 2020-06-11
First Post: 2018-06-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CTA Expression/Methylation and Response to Pembrolizumab of NSCLC Patients
Sponsor: Medical University of Vienna
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module